Actively Recruiting
Pilot Trial Investigating Every Other Day Dosing of Oral Iron in Premature Infants (IQONic)
Led by CHRISTUS Health · Updated on 2024-08-15
100
Participants Needed
1
Research Sites
86 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Study focuses on determining if daily versus every-other-day (EOD) oral iron at the same dose per kilogram per day will achieve similar incidence of iron replete status at 36 weeks post-menstrual age in premature neonates
CONDITIONS
Official Title
Pilot Trial Investigating Every Other Day Dosing of Oral Iron in Premature Infants (IQONic)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children (minor under 18 years of age)
- Neonates
- Hospitalized premature infants
- Premature infants on full enteral feeds and started on oral iron
- Premature infants born between 26 0/7 and 32 6/7 weeks' gestation
You will not qualify if you...
- Infants with known congenital anomalies or chromosomal abnormalities such as Trisomy 18 or Trisomy 21
- Infants with conditions that affect iron metabolism like thalassemia or hemochromatosis
- Infants with bleeding disorders or coagulopathy
- Infants who received iron parenterally before randomization
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHRISTUS Children's
San Antonio, Texas, United States, 78207
Actively Recruiting
Research Team
R
Rosario Ocampo
CONTACT
D
Donna Rodney
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here